GSA Capital Partners’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-148,757
| Closed | -$1.31M | – | 2194 |
|
|
2025
Q4 | $1.31M | Sell |
148,757
-170,042
| -53% | -$936K | 0.11% | 226 |
|
|
2025
Q3 | $1.59M | Sell |
318,799
-63,272
| -17% | -$293K | 0.13% | 155 |
|
|
2025
Q2 | $1.8M | Buy |
382,071
+121,856
| +47% | +$533K | 0.13% | 157 |
|
|
2025
Q1 | $1.19M | Buy |
260,215
+121,797
| +88% | +$568K | 0.11% | 261 |
|
|
2024
Q4 | $663K | Buy |
138,418
+107,995
| +355% | +$519K | 0.05% | 698 |
|
|
2024
Q3 | $143K | Buy |
+30,423
| New | +$163K | 0.01% | 1453 |
|
|
2024
Q2 | – | Sell |
-489,324
| Closed | -$2.01M | – | 2052 |
|
|
2024
Q1 | $2.01M | Sell |
489,324
-78,432
| -14% | -$314K | 0.16% | 101 |
|
|
2023
Q4 | $2.4M | Buy |
567,756
+161,737
| +40% | +$653K | 0.2% | 72 |
|
|
2023
Q3 | $1.75M | Buy |
406,019
+245,495
| +153% | +$1.36M | 0.15% | 148 |
|
|
2023
Q2 | $1.06M | Buy |
160,524
+73,187
| +84% | +$469K | 0.11% | 273 |
|
|
2023
Q1 | $593K | Sell |
87,337
-38,029
| -30% | -$267K | 0.06% | 605 |
|
|
2022
Q4 | $926K | Buy |
125,366
+73,500
| +142% | +$716K | 0.11% | 249 |
|
|
2022
Q3 | $512K | Buy |
+51,866
| New | +$548K | 0.07% | 554 |
|
|
2022
Q2 | – | Sell |
-28,482
| Closed | -$322K | – | 1829 |
|
|
2022
Q1 | $322K | Buy |
28,482
+10,390
| +57% | +$137K | 0.04% | 844 |
|
|
2021
Q4 | $284K | Buy |
+18,092
| New | +$315K | 0.04% | 973 |
|
|
2020
Q1 | – | Sell |
-22,135
| Closed | -$363K | – | 1590 |
|
|
2019
Q4 | $363K | Sell |
22,135
-30,459
| -58% | -$461K | 0.04% | 878 |
|
|
2019
Q3 | $698K | Buy |
+52,594
| New | +$733K | 0.09% | 337 |
|
|
2019
Q1 | – | Sell |
-11,945
| Closed | -$312K | – | 1716 |
|
|
2018
Q4 | $312K | Sell |
11,945
-4,253
| -26% | -$100K | 0.04% | 816 |
|
|
2018
Q3 | $372K | Buy |
+16,198
| New | +$331K | 0.02% | 1221 |
|
|
2017
Q1 | – | Sell |
-14,535
| Closed | -$232K | – | 2011 |
|
|
2016
Q4 | $232K | Sell |
14,535
-3,269
| -18% | -$52.5K | 0.01% | 1502 |
|
|
2016
Q3 | $296K | Buy |
+17,804
| New | +$240K | 0.02% | 1382 |
|
|
2016
Q2 | – | Sell |
-31,180
| Closed | -$261K | – | 1934 |
|
|
2016
Q1 | $261K | Buy |
31,180
+7,341
| +31% | +$60.3K | 0.02% | 1372 |
|
|
2015
Q4 | $222K | Sell |
23,839
-28,831
| -55% | -$288K | 0.01% | 1606 |
|
|
2015
Q3 | $594K | Buy |
+52,670
| New | +$644K | 0.03% | 1030 |
|
|
2014
Q3 | – | Sell |
-14,828
| Closed | -$240K | – | 1946 |
|
|
2014
Q2 | $240K | Sell |
14,828
-12,710
| -46% | -$169K | 0.01% | 1526 |
|
|
2014
Q1 | $447K | Buy |
+27,538
| New | +$392K | 0.03% | 862 |
|
|
2013
Q4 | – | Sell |
-10,212
| Closed | -$112K | – | 1780 |
|
|
2013
Q3 | $112K | Buy |
+10,212
| New | +$109K | 0.01% | 1486 |
|
Other funds holding VNDA
ACM
VCM
